6-Phenylnicotinic acid, 97%

Name: 6-Phenylnicotinic acid, 97% | 29051-44-3
Brand: J&K Chemical
SKU: JK181302_250_MG
Price: 12.7 USD
Availability: InStock

Cat. No JK181302_250_MG

Vendor: J&K Chemical

Product Information

Product Name

6-Phenylnicotinic acid, 97%

Brand Name

J&K

Product Number

181302

CAS

29051-44-3

Molecular Formula

C12H9NO2

Molecular Weight

199.21

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

120118

Properties

Melting Point

230 - 234

Safety Information

Storage Condition

Store at 2-8℃

References Data Source From Pubchem

Gas Chromatography with Modified pH-Sensitive Pellets in Evaluating Esterase Activity of Carbonic Anhydrase III Enzyme: Drug Discovery Approach

Publication Name: Chromatographia

Publication Date: 2021-10-22

DOI: 10.1007/s10337-021-04101-3

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking

Publication Name: Science Advances

Publication Date: 2021-04-16

DOI: 10.1126/sciadv.abf8711

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

Publication Name: Medicinal Chemistry Research

Publication Date: 2017-03-17

DOI: 10.1007/s00044-017-1825-x

Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors

Publication Name: Journal of Medicinal Chemistry

Publication Date: 2013-01-09

DOI: 10.1021/jm3014844

Pyridine bases derived from 1-buten-3-ynes

Publication Name: Bulletin of the Academy of Sciences of the USSR, Division of chemical science

Publication Date: 1961-10

DOI: 10.1007/bf00911446

6-Phenylnicotinic acid, 97%

Product Information

General Information

Properties

Safety Information

References Data Source From Pubchem

Gas Chromatography with Modified pH-Sensitive Pellets in Evaluating Esterase Activity of Carbonic Anhydrase III Enzyme: Drug Discovery Approach

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking

6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer

Fragment Growing and Linking Lead to Novel Nanomolar Lactate Dehydrogenase Inhibitors

Pyridine bases derived from 1-buten-3-ynes